Orchid Ventures, Inc. ORVRF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

47/100

1/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Orchid Ventures, Inc. (ORVRF) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 43/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score

47/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

50/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

36/100

→ Income

✓

成长

100/100

→ Income

—

收入

N/A

No coverage

估值概览 — ORVRF

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$0.00

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2014	$-0.10	$0.00	$-167.98K	-
2015	$-0.16	$0.00	$-92.11K	-
2016	$-0.13	$0.00	$-74.72K	-
2017	$-0.38	$0.00	$-225.17K	-
2018	$-0.03	$2.47M	$-137.14K	-5.5%
2019	$-3.39	$5.51M	$-6.69M	-121.4%
2020	$-0.49	$1.43M	$-6.42M	-449.6%
2021	$-0.06	$3.72M	$-3.15M	-84.7%
2022	$0.00	$0.00	$0.00	-
2023	$0.00	$0.00	$0.00	-